Brief: Somalogic Q1 Revenue USD 20.4 Mln
11/05/2023 21:07
May 11 (Reuters) - Somalogic Q1 adjusted EBITDA USD -36.445 million. * Q1 net income USD -34.202 million * Q1 basic EPS USD -0.18 * Q1 revenue USD 20.4 million * Q1 gross margin 39.6%
Recent news on Somalogic
See all newsBrief: Somalogic Stockholders Vote To Approve Standard Biotools Transaction At Special Meeting
Brief: Madryn Asset Management Demands Somalogic’S Board Address Repeated, Unprecedented Adjournments Of Tainted Special Meeting
Brief: Madryn Asset Management Says It Urges All Somalogic Shareholders To Oppose Transaction With Standard Biotools
Brief: Madryn Asset Management Urges Shareholders To Vote “Against” The Proposed Merger And Allow Somalogic To Pursue Value-Enhancing Alternatives
Brief: Somalogic Board Reiterates Value-Maximizing Transaction With Standard Biotools Is In Best Interests Of All Stockholders